FDA Committee Nixes Opioid With Blue Dye Deterrent FDA Committee Nixes Opioid With Blue Dye Deterrent

Lack of safety data on the dye and of abuse potential led to the vote against recommending approval of an extended-release oxycodone product intended to deter intravenous abuse.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news